Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial

Norikazu Masuda(Osaka National Hospital), Yasuaki Sagara(National Sagamihara Hospital), Takayuki Kinoshita(Tokyo National Hospital), Hiroji Iwata(Aichi Cancer Center), Seigo Nakamura(Showa University), Yasuhiro Yanagita(Gunma Children's Medical Center), Reiki Nishimura(Kumamoto City Hospital), Hirotaka Iwase(Kumamoto University), Shunji Kamigaki(Sakai Municipal Hospital), Hiroyuki Takei(Saitama Cancer Center), Shinzaburo Noguchi(Osaka University)
The Lancet Oncology
January 21, 2012
Cited by 177

Abstract


Related Papers

No related papers found

Powered by citation graph analysis